Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise
Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise
Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise